ELI LILLY & Co
Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%
Eli Lilly U.S. GTN cash payments of rebates, discounts & returns by Year
U.S. GTN cash payments of rebates, discounts & returns ($M) ($M)
Eli Lilly U.S. GTN cash payments of rebates, discounts & returns: -$57,299M in FY2025, up 37.1% from a year earlier. That is the lowest of the 10 years on record here.
Where the FY2025 figure comes from
“|| Cash payments | (57,299) | (41,807)”
Source: Form 10-K FY2025 (filed 2026-02-12) ↗
Reported in Form 10-K Item 7 GTN Rollforward Table.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | U.S. GTN cash payments of rebates, discounts & returns ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -57,299 | +37.1% | Form 10-K FY2025 (filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | -41,807 | +18.1% | Form 10-K FY2024 (filed 2025-02-19) ↗ |
| FY2023 | Dec 31, 2023 | -35,413 | +34.4% | Form 10-K FY2023 (filed 2024-02-21) ↗ |
| FY2022 | Dec 31, 2022 | -26,346 | +36.2% | Form 10-K FY2022 (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | -19,345 | +8.0% | Form 10-K FY2021 (filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | -17,904 | +15.3% | Form 10-K FY2020 (filed 2021-02-17) ↗ |
| FY2019 | Dec 31, 2019 | -15,526 | +29.1% | Form 10-K FY2019 (filed 2020-02-19) ↗ |
| FY2018 | Dec 31, 2018 | -12,023 | +19.8% | Form 10-K FY2018 (filed 2019-02-19) ↗ |
| FY2017 | Dec 31, 2017 | -10,033 | +30.5% | Form 10-K FY2017 (filed 2018-02-20) ↗ |
| FY2016 | Dec 31, 2016 | -7,690 | – | Form 10-K FY2017 (filed 2018-02-20) ↗ |
Cite this data
StockData. (2026). Eli Lilly U.S. GTN cash payments of rebates, discounts & returns ($M), annual FY2016–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/gtn-us-payments
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.